000279043 001__ 279043
000279043 005__ 20250713001350.0
000279043 0247_ $$2doi$$a10.1016/j.arr.2025.102771
000279043 0247_ $$2pmid$$apmid:40373984
000279043 0247_ $$2ISSN$$a1568-1637
000279043 0247_ $$2ISSN$$a1872-9649
000279043 0247_ $$2altmetric$$aaltmetric:177137992
000279043 037__ $$aDZNE-2025-00673
000279043 041__ $$aEnglish
000279043 082__ $$a610
000279043 1001_ $$0P:(DE-2719)9000739$$aSchaumburg, Malika$$b0$$eFirst author$$udzne
000279043 245__ $$aImmersive virtual reality for older adults: Challenges and solutions in basic research and clinical applications.
000279043 260__ $$aOxford [u.a.]$$bElsevier$$c2025
000279043 3367_ $$2DRIVER$$aarticle
000279043 3367_ $$2DataCite$$aOutput Types/Journal article
000279043 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1749559415_16644$$xReview Article
000279043 3367_ $$2BibTeX$$aARTICLE
000279043 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000279043 3367_ $$00$$2EndNote$$aJournal Article
000279043 520__ $$aImmersive virtual reality (IVR) offers significant potential for aging research, providing a controlled yet ecologically valid platform for studying cognitive, emotional, and motor processes, as well as supporting interventions and diagnostic assessments in older adults. However, its usability can be hindered by age-related sensory, motor, and cognitive changes, which may contribute to anxiety, disorientation, and reduced task engagement. In this narrative review, we examine the challenges older adults face with IVR and explore strategies to optimize its design for this population. These challenges include negative attitudes, sensory and motor limitations, and cognitive decline, all of which influence interaction with virtual environments. Based on these insights, we discuss design considerations such as self-paced interactions, simplified control mechanisms, task-relevant visual and auditory adjustments, and structured training protocols to enhance engagement. Additionally, we highlight strategies to minimize cognitive load and physical discomfort, supporting the development of IVR applications that are both effective and accessible for aging populations.
000279043 536__ $$0G:(DE-HGF)POF4-353$$a353 - Clinical and Health Care Research (POF4-353)$$cPOF4-353$$fPOF IV$$x0
000279043 588__ $$aDataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
000279043 650_7 $$2Other$$aCognitive Aging
000279043 650_7 $$2Other$$aCybersickness
000279043 650_7 $$2Other$$aHuman-Computer Interaction
000279043 650_7 $$2Other$$aImmersive virtual reality
000279043 650_7 $$2Other$$aMedical XR
000279043 650_7 $$2Other$$aSensorimotor decline
000279043 650_2 $$2MeSH$$aHumans
000279043 650_2 $$2MeSH$$aVirtual Reality
000279043 650_2 $$2MeSH$$aAging: psychology
000279043 650_2 $$2MeSH$$aAging: physiology
000279043 650_2 $$2MeSH$$aAged
000279043 650_2 $$2MeSH$$aCognition
000279043 7001_ $$0P:(DE-2719)2812809$$aImtiaz, Ashar$$b1$$udzne
000279043 7001_ $$0P:(DE-2719)2812106$$aZhou, Ruojing$$b2$$udzne
000279043 7001_ $$0P:(DE-2719)9002387$$aBernard, Matthieu$$b3$$udzne
000279043 7001_ $$0P:(DE-2719)2810583$$aWolbers, Thomas$$b4$$udzne
000279043 7001_ $$0P:(DE-2719)9001409$$aSegen, Vladislava$$b5$$eLast author$$udzne
000279043 773__ $$0PERI:(DE-600)2099320-1$$a10.1016/j.arr.2025.102771$$gVol. 109, p. 102771 -$$p102771$$tAgeing research reviews$$v109$$x1568-1637$$y2025
000279043 8564_ $$uhttps://pub.dzne.de/record/279043/files/DZNE-2025-00673.pdf$$yOpenAccess
000279043 8564_ $$uhttps://pub.dzne.de/record/279043/files/DZNE-2025-00673.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000279043 909CO $$ooai:pub.dzne.de:279043$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
000279043 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9000739$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b0$$kDZNE
000279043 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2812809$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b1$$kDZNE
000279043 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2812106$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b2$$kDZNE
000279043 9101_ $$0I:(DE-HGF)0$$6P:(DE-2719)9002387$$aExternal Institute$$b3$$kExtern
000279043 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2810583$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b4$$kDZNE
000279043 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9001409$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b5$$kDZNE
000279043 9131_ $$0G:(DE-HGF)POF4-353$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vClinical and Health Care Research$$x0
000279043 9141_ $$y2025
000279043 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-21
000279043 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-21
000279043 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2024-12-21
000279043 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2024-12-21
000279043 915__ $$0LIC:(DE-HGF)CCBYNC4$$2HGFVOC$$aCreative Commons Attribution-NonCommercial CC BY-NC 4.0
000279043 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-21
000279043 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-21
000279043 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000279043 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2024-12-21
000279043 915__ $$0StatID:(DE-HGF)1120$$2StatID$$aDBCoverage$$bBIOSIS Reviews Reports And Meetings$$d2024-12-21
000279043 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-21
000279043 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2024-12-21$$wger
000279043 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-21
000279043 9201_ $$0I:(DE-2719)1310002$$kAG Wolbers$$lAging, Cognition and Technology$$x0
000279043 980__ $$ajournal
000279043 980__ $$aVDB
000279043 980__ $$aUNRESTRICTED
000279043 980__ $$aI:(DE-2719)1310002
000279043 9801_ $$aFullTexts